Medtronic Evolut TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years Medical Device Investing
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest Medical Device Investing
AMGEN PRESENTS NEW LUMAKRAS® PLUS VECTIBIX® DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER Market News
FDA Approves Cabtreo Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older Pharmaceutical Investing